leisure time -WSS

leisure time

author：knowledge 2025-09-06 02:04:54 - browse：81373

Surgeons look over an x-ray monitor showing an implanted pacemaker — coverage from STAT — Adobe

In her final presentation for health policy class at the University of Chicago, first-year medical student Robin Ji informed her classmates that the Food and Drug Administration does not require randomized controlled trials of most medical devices. Her peers’ immediate reaction was disbelief.

“One classmate kept asking me, are you sure?” Ji said. “I think he asked me twice. Then he went on his phone to check to see if it was actually true.”

Ji was sure. She had spent two years before going to medical school working as a policy analyst for Rita Redberg and Sanket Dhruva, medical safety experts at the University of California, San Francisco. In a recent national survey published by the UCSF team in Health Affairs, Ji learned that it’s not just her classmates who may have misconceptions about the FDA — only 17% of physicians surveyed felt they understood the FDA’s device approval process. Around 41% felt they understood the drug side.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Food makers to regulators: Ultra

explore

leisure time

WSS

Readout LOUD podcast: How biotech is using artificial intelligence

New weight loss drugs vying to be the next Wegovy or Mounjaro

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

For Medicare Advantage, Democrats want stronger protections around AI

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

FDA approves updated Covid vaccines

focus

leisure time

focus

Bright Health sells Medicare Advantage business to Molina

Readout LOUD podcast: How biotech is using artificial intelligence

Medical leaders decry Supreme Court decision on affirmative action

Generate Biomedicines machine learning biotech raises $273M

Anesthesiologist group: stop taking Ozempic before surgery

Biogen Alzheimer’s drug launch off to slow start

Peter Hotez and the public health issue of online harassment

To avoid data mishandling cases, universities eye AI and other tools

Hepatitis C has a cure — but many Americans still lack access to it

How medical schools plan to diversify without affirmative action

focus

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Senators start work on Medicare physician payment reform

Biden report: The neurospychology of memory and aging

Regeneron agrees to White House price limits on anti

Hospitals consider fixing cancer drug shortages on their own

What we’ve learned from the Aduhelm mess

Wikipedia

explore

leisure time

hotspot